Conditional knockout of CTGF affects corneal wound healing

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2062-2070

  Gibson, Daniel J ^a   Pi, Liya ^b   Sriram, Sriniwas ^c   Mao, Cong ^d   Petersen, Bryon E ^b   Scott, Edward W ^a   Leask, Andrew ^e   Schultz, Gregory S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Florida   (United States)

^d SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

Animal models; CTGF; Pre fibrosis

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCEIN; MELOXICAM; UBIQUITIN C;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA INJURY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; GENE DELETION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IRIS; KERATECTOMY; KNOCKOUT MOUSE; LASER SURGERY; LENS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL TECHNIQUE; UPREGULATION; VASCULARIZATION; WOUND CLOSURE; WOUND HEALING;

ANIMAL MODELS; CTGF; PRE-FIBROSIS;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; CORNEA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INJURIES; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; WOUND HEALING;

EID: 84897550534     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12735     Document Type: Article

References (34)

1. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp Eye Res. 2004;78:553-560.
2. Maldonado MJ. Intraoperative MMC after excimer laser surgery for myopia. Ophthalmology. 2002;109:826, author reply 826-828.
3. Coppens G, Maudgal P. Corneal complications of intraoperative Mitomycin C in glaucoma surgery. Bull Soc Belge Ophtalmol. 2010;19-23.
4. Kopp ED, Seregard S. Epiphora as a side effect of topical mitomycin C. Br J Ophthalmol. 2004;88:1422-1424.
5. Lane HA, Swale JA, Majmudar PA. Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap. J Cataract Refract Surg. 2003;29:390-392.
6. Netto MV, Mohan RR, Ambrosio R Jr, Hutcheon AE, Zieske JD, Wilson SE. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea. 2005;24:509-522.
7. Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg. 2006;22:562-574.
8. Roh DS, Funderburgh JL. Impact on the corneal endothelium of mitomycin C during photorefractive keratectomy. J Refract Surg. 2009;25:894-897.
9. Santhiago MR, Netto MV, Wilson SE. Mitomycin C: biological effects and use in refractive surgery. Cornea. 2012;31:311-321.
10. Zhivov A, Beck R, Guthoff RF. Corneal and conjunctival findings after mitomycin C application in pterygium surgery: an in-vivo confocal microscopy study. Acta Ophthalmol. 2009; 87:166-172.
11. Ferguson MW, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT. Scar formation: the spectral nature of fetal and adult wound repair. Plast Reconstruct Surg. 1996;97:854-860.
12. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, Adzick NS. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg. 1994;219:65-72.
13. Sullivan KM, Lorenz HP, Meuli M, Lin RY, Adzick NS. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg. 1995;30: 198-202, discussion 202-203.
14. Franch HA, Shay JW, Alpern RJ, Preisig PA. Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. J Cell Biol. 1995;129:245-254.
15. Laping NJ, Everitt JI, Frazier KS, et al. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats. Clin Cancer Res. 2007;13:3087-3099.
16. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997;8:171-179.
17. Daniels JT, Schultz GS, Blalock TD, et al. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol. 2003;163:2043-2052.
18. Blalock TD, Duncan MR, Varela JC, et al. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2003;44:1879-1887.
19. Blalock TD, Yuan R, Lewin AS, Schultz GS. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation. Exp Eye Res. 2004;78:1127-1136.
20. Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001 [press release]. Carlsbad: Excaliard Pharmaceuticals I; August 3, 2010.
21. Shi L, Chang Y, Yang Y, Zhang Y, Yu FS, Wu X. Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing. PLoS One. 2012;7:e32128.
22. Yang YM, Wu XY, Du LQ. The role of connective tissue growth factor, transforming growth factor and Smad signaling pathway during corneal wound healing [in Chinese]. Zhonghua Yan Ke Za Zhi. 2006;42:918-924.
23. Ivkovic S, Yoon BS, Popoff SN, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003;130:2779-2791.
24. Blake J, Bult C, Kadin J, Richardson J, Eppig J, Group Mouse Genome Database Group. The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res. 2011;39:D842-D848.
25. Kapoor M, Liu S, Huh K, Parapuram S, Kennedy L, Leask A. Connective tissue growth factor promoter activity in normal and wounded skin. Fibrogenesis Tissue Repair. 2008;1:3.
26. Nayfield SG, Gorin MB. Tamoxifen-associated eye disease. A review. J Clin Oncol. 1996;14:1018-1026.
27. Liu S, Shi-wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum. 2011;63:239-246.
28. Gibson DJ, Schultz GS. Ectopic epithelial implants following surface ablation of the cornea. Invest Ophthalmol Vis Sci. 2012;53:7760-7765.
29. Gibson DJ, Tuli SS, Schultz GS. The progression of haze formation in rabbit corneas following phototherapeutic keratectomy. Invest Ophthalmol Vis Sci. 2013;16:4776-4781.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods. 2001;25:402-408.
31. Pi L, Xia H, Liu J, Shenoy AK, Hauswirth WW, Scott EW. Role of connective tissue growth factor in the retinal vasculature during development and ischemia. Invest Ophthalmol Vis Sci. 2011;52:8701-8710.
32. Robinson PM, Smith TS, Patel D, et al. Proteolytic processing of connective tissue growth factor in normal ocular tissues and during corneal wound healing. Invest Ophthalmol Vis Sci. 2012;53:8093-8103.
33. Pi L, Shenoy AK, Liu J, et al. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J. 2012;26: 3365-3379.
34. Secker GA, Shortt AJ, Sampson E, Schwarz QP, Schultz GS, Daniels JT. TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res. 2008;314: 131-142.